biospecimen_aliquot__bcr_aliquot_barcode	tcga-ar-a1ak-01a-21d-a12q-09
biospecimen_aliquot__bcr_aliquot_uuid	52f7c22f-84cb-4263-93bf-1ae8cf8abbd2
biospecimen_aliquot__bcr_patient_uuid	94b03e1d-50ec-4680-bffd-7086d1536ff2
biospecimen_aliquot__bcr_sample_barcode	tcga-ar-a1ak-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0108431832
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.09
biospecimen_aliquot__date_of_shipment	2011-02-22
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a12q
biospecimen_aliquot__plate_row	f
biospecimen_aliquot__quantity	3.60
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	1.85
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-ar-a1ak-01a-21d
biospecimen_analyte__bcr_analyte_uuid	07f6d646-0c1d-4f9f-8620-9edd575cf71b
biospecimen_analyte__bcr_patient_uuid	94b03e1d-50ec-4680-bffd-7086d1536ff2
biospecimen_analyte__bcr_sample_barcode	tcga-ar-a1ak-01a
biospecimen_analyte__concentration	0.17
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-ar-a1ak
biospecimen_diagnostic_slides__bcr_patient_uuid	94b03e1d-50ec-4680-bffd-7086d1536ff2
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-ar-a1ak-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	0affa0b5-d1a6-43e9-892a-7cb16a79e5f9
biospecimen_normal_control__bcr_patient_barcode	tcga-ar-a1ak
biospecimen_normal_control__bcr_patient_uuid	94b03e1d-50ec-4680-bffd-7086d1536ff2
biospecimen_normal_control__ncedna_dna_conc	0.25
biospecimen_normal_control__ncedna_dna_qm	nanodrop,nd-1000 spectrophotometer
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	80
biospecimen_portion__bcr_patient_uuid	94b03e1d-50ec-4680-bffd-7086d1536ff2
biospecimen_portion__bcr_portion_barcode	tcga-ar-a1ak-01a-21
biospecimen_portion__bcr_portion_uuid	4c1f9cba-5d74-4d37-af59-743079d9cf0c
biospecimen_portion__bcr_sample_barcode	tcga-ar-a1ak-01a
biospecimen_portion__date_of_creation	2011-02-03
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	21
biospecimen_portion__portion_sequence	2
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-ar-a1ak-01a-21d
biospecimen_protocol__bcr_patient_uuid	94b03e1d-50ec-4680-bffd-7086d1536ff2
biospecimen_protocol__bcr_sample_barcode	tcga-ar-a1ak-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	94b03e1d-50ec-4680-bffd-7086d1536ff2
biospecimen_sample__bcr_sample_barcode	tcga-ar-a1ak-01a
biospecimen_sample__bcr_sample_uuid	fe0ddcfc-f6e9-460d-b8e6-5187ffe8eb4f
biospecimen_sample__days_to_collection	1744
biospecimen_sample__initial_weight	490
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-ar-a1ak.f4dbfc71-9cd0-41c3-9f20-77fa0605d4a8.pdf
biospecimen_sample__pathology_report_uuid	f4dbfc71-9cd0-41c3-9f20-77fa0605d4a8
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	94b03e1d-50ec-4680-bffd-7086d1536ff2
biospecimen_shipment_portion__bcr_sample_barcode	tcga-ar-a1ak-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	f0e4daf7-c2e8-40e8-826e-1cb9df14327e
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13e
biospecimen_shipment_portion__portion_number	31
biospecimen_shipment_portion__portion_sequence	3
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-ar-a1ak-01a-31-a13e-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	94b03e1d-50ec-4680-bffd-7086d1536ff2
biospecimen_slide__bcr_sample_barcode	tcga-ar-a1ak-01a
biospecimen_slide__bcr_slide_barcode	tcga-ar-a1ak-01a-02-tsb
biospecimen_slide__bcr_slide_uuid	4cd7ad23-1a24-4289-a684-27e2b5e5e8df
biospecimen_slide__image_file_name	tcga-ar-a1ak-01a-02-tsb.4cd7ad23-1a24-4289-a684-27e2b5e5e8df.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	5
biospecimen_slide__percent_stromal_cells	30
biospecimen_slide__percent_tumor_cells	65
biospecimen_slide__percent_tumor_nuclei	80
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-ar-a1ak
biospecimen_tumor_sample__bcr_patient_uuid	94b03e1d-50ec-4680-bffd-7086d1536ff2
clinical_drug__bcr_drug_barcode	tcga-ar-a1ak-d22155
clinical_drug__bcr_drug_uuid	37d99581-850d-476b-8328-d3e0bd6dc049
clinical_drug__bcr_patient_barcode	tcga-ar-a1ak
clinical_drug__bcr_patient_uuid	94b03e1d-50ec-4680-bffd-7086d1536ff2
clinical_drug__form_completion_date	2012-3-1
clinical_drug__pharmaceutical_therapy_drug_name	anastrozole
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_dose_units	mg/day
clinical_drug__pharmaceutical_tx_ended_days_to	1843
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	33
clinical_drug__prescribed_dose	1
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	po
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-ar-a1ak-f22154
clinical_follow_up__bcr_followup_uuid	df7ef2e1-3f76-4517-a7b5-8a638431a253
clinical_follow_up__bcr_patient_barcode	tcga-ar-a1ak
clinical_follow_up__bcr_patient_uuid	94b03e1d-50ec-4680-bffd-7086d1536ff2
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2012-3-1
clinical_follow_up__last_contact_days_to	1559
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	70
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0
clinical_patient__ajcc_pathologic_tumor_stage	stage i
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t1
clinical_patient__anatomic_neoplasm_subdivision	right
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-ar-a1ak
clinical_patient__bcr_patient_uuid	94b03e1d-50ec-4680-bffd-7086d1536ff2
clinical_patient__birth_days_to	-25825
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	10-19%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-6-15
clinical_patient__gender	female
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2006
clinical_patient__last_contact_days_to	1559
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	5
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	yes
clinical_patient__patient_id	a1ak
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	10-19%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	simple mastectomy
clinical_patient__tissue_source_site	ar
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AR-A1AK-01A-21D-A12Q-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AR-A1AK-01A-21D-A12Q-09.bed.meta
manually_curated__id	tcga-ar-a1ak-01a-21d-a12q-09
manually_curated__md5sum	50f05304e40557db58a84943c0c622bc
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	52f7c22f-84cb-4263-93bf-1ae8cf8abbd2
manually_curated__tumor_tag	brca
